{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A panel of expert advisers to the Food and Drug Administration told the agency today that there was no sound evidence to conclude that the prescription drug Prozac or any other antidepressant caused suicide or other violent behavior. As a result of that unanimous finding, the advisers voted, 6 to 3, to recommend against any labeling changes that would warn users of the drug that it posed a suicide risk.", "headline": {"main": "Warning Label on Antidepressant Is Opposed"}, "abstract": null, "print_page": "22", "word_count": 402, "_id": "4fd1c99f8eb7c8105d6fd36c", "snippet": "A panel of expert advisers to the Food and Drug Administration told the agency today that there was no sound evidence to conclude that the prescription drug Prozac or any other antidepressant caused suicide or other violent behavior.   As a result of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/09/21/us/warning-label-on-antidepressant-is-opposed.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "ANTIDEPRESSANTS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"organization": "AP", "original": "AP", "person": []}, "document_type": "article", "pub_date": "1991-09-21T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "In November 1989, the United States Consumer Product Safety Commission determined that a popular portable heater might pose a fire risk. But it did not alert the public until last month, after the manufacturer agreed to fix 3.6 million units. In those 21 months, while the agency and company investigated and negotiated, eight people died in two fires that may have been started by faulty wiring in the heaters, said David Fonvielle, a lawyer in Tallahassee, Fla., for plaintiffs in some of these cases. The manufacturer, DeLonghi S.p.A, said the units caused no fires.", "headline": {"main": "Product Safety Commission Is Criticized as Too Slow to Act"}, "abstract": null, "print_page": "46", "word_count": 1484, "_id": "4fd1d3488eb7c8105d70f9c1", "snippet": "In November 1989, the United States Consumer Product Safety Commission determined that a popular portable heater might pose a fire risk. But it did not alert the public until last month, after the manufacturer agreed to fix 3.6 million units.   In...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/09/21/news/product-safety-commission-is-criticized-as-too-slow-to-act.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "CONSUMER PRODUCT SAFETY COMMISSION"}, {"name": "subject", "value": "ACCIDENTS AND SAFETY"}, {"name": "subject", "value": "COMPANY AND ORGANIZATION PROFILES"}, {"name": "subject", "value": "CONSUMER PROTECTION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Barry", "lastname": "MEIER"}], "original": "By BARRY MEIER"}, "document_type": "article", "pub_date": "1991-09-21T00:00:00Z", "section_name": null}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "FOR some time, a few doctors have quietly been offering a few frightened women a powerful drug they hope will prevent breast cancer. Now the National Cancer Institute is poised to begin an enormous study to see if the treatment works. The drug is tamoxifen, a synthetic hormone that blocks the action of the female hormone estrogen in the breast, depriving many cancers of the fuel that feeds them. In the study, 16,000 women will be randomly assigned to take tamoxifen or a dummy pill for five years. If the five-year study shows that the hormone prevents cancer, millions of women will probably be advised to take it for the rest of their lives.", "headline": {"main": "Powerful Hormone to Be Tested In War to Prevent Breast Cancer"}, "abstract": null, "print_page": "11", "word_count": 1602, "_id": "4fd1c9988eb7c8105d6fce96", "snippet": "FOR some time, a few doctors have quietly been offering a few frightened women a powerful drug they hope will prevent breast cancer. Now the National Cancer Institute is poised to begin an enormous study to see if the treatment works.   The drug is...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/09/18/health/powerful-hormone-to-be-tested-in-war-to-prevent-breast-cancer.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "TERMS NOT AVAILABLE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1991-09-18T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "At first glance, Sally Berg looks like a perfect candidate for estrogen replacement therapy. She entered menopause early. She is very thin, so she risks bone loss through osteoporosis. And though her father lived to the age of 65, he had a massive heart attack at 38. So Ms. Berg is just the kind of woman researchers believe would be helped by the hormone's bone-saving and heart-saving properties.", "headline": {"main": "After Breast Cancer, Women Face Dilemma Over Estrogen Therapy"}, "abstract": null, "print_page": "6", "word_count": 1024, "_id": "4fd1acc18eb7c8105d6cc8b6", "snippet": "At first glance, Sally Berg looks like a perfect candidate for estrogen replacement therapy.   She entered menopause early. She is very thin, so she risks bone loss through osteoporosis. And though her father lived to the age of 65, he had a massive...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/09/17/science/after-breast-cancer-women-face-dilemma-over-estrogen-therapy.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "MENOPAUSE"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1991-09-17T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 4, "offset": 0, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}